相似文献
1
MRI of localized prostate cancer: coming of age in the PSA era.
Diagn Interv Radiol. 2012 Jan-Feb;18(1):34-45. doi: 10.4261/1305-3825.DIR.4478-11.1. Epub 2011 Sep 16.
2
Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI.
Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):743-50. doi: 10.1016/j.ijrobp.2009.08.040. Epub 2010 Feb 3.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
Int J Radiat Oncol Biol Phys. 1995 Aug 30;33(1):23-35. doi: 10.1016/0360-3016(95)00154-Q.
5
Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
Cancer Invest. 1995;13(1):31-5. doi: 10.3109/07357909509024892.
6
The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer.
Semin Urol Oncol. 1998 Aug;16(3):100-5.
7
Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer.
J Urol. 2000 Sep;164(3 Pt 1):759-63. doi: 10.1097/00005392-200009010-00032.
8
Multiparametric MRI in detection and staging of prostate cancer.
Dan Med J. 2017 Feb;64(2).
9
Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging.
BJU Int. 2007 Jan;99(1):41-5. doi: 10.1111/j.1464-410X.2006.06515.x.
10
[Active surveillance for prostate cancer].
Prog Urol. 2015 Nov;25(14):884-7. doi: 10.1016/j.purol.2015.06.010. Epub 2015 Jul 14.
引用本文的文献
1
Automatic Prostate Cancer Segmentation Using Kinetic Analysis in Dynamic Contrast-Enhanced MRI.
J Biomed Phys Eng. 2018 Mar 1;8(1):107-116. eCollection 2018 Mar.
2
Role of mpMRI of the prostate in screening for prostate cancer.
Transl Androl Urol. 2017 Jun;6(3):464-471. doi: 10.21037/tau.2017.04.31.
3
Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
J Magn Reson Imaging. 2017 Jul;46(1):184-193. doi: 10.1002/jmri.25562. Epub 2016 Dec 19.
4
Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
J Magn Reson Imaging. 2016 Dec;44(6):1405-1414. doi: 10.1002/jmri.25330. Epub 2016 Jun 10.
5
Image-guided focal therapy for prostate cancer.
Diagn Interv Radiol. 2014 Nov;20(6):492-7. doi: 10.5152/dir.2014.14134.
6
Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors.
J Magn Reson Imaging. 2015 May;41(5):1383-93. doi: 10.1002/jmri.24676. Epub 2014 Jun 18.
7
Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.
Diagn Interv Radiol. 2014 May-Jun;20(3):229-33. doi: 10.5152/dir.2014.13322.
8
Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session.
Diagn Interv Radiol. 2014 May-Jun;20(3):234-8. doi: 10.5152/dir.2014.13345.
9
MR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation.
Radiology. 2014 May;271(2):452-60. doi: 10.1148/radiol.14131374. Epub 2014 Feb 1.
10
Prostate MRI: access to and current practice of prostate MRI in the United States.
J Am Coll Radiol. 2014 Feb;11(2):156-60. doi: 10.1016/j.jacr.2013.05.006. Epub 2014 Jan 2.
本文引用的文献
1
An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy.
J Urol. 2010 Dec;184(6):2320-7. doi: 10.1016/j.juro.2010.07.037. Epub 2010 Oct 16.
2
Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?
Diagn Interv Radiol. 2011 Sep;17(3):243-8. doi: 10.4261/1305-3825.DIR.3605-10.1. Epub 2010 Sep 22.
3
The value of diffusion-weighted MRI for prostate cancer detection and localization.
Diagn Interv Radiol. 2011 Jun;17(2):130-4. doi: 10.4261/1305-3825.DIR.3399-10.1. Epub 2010 Aug 6.
4
Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study.
J Natl Cancer Inst. 2010 Jul 7;102(13):950-8. doi: 10.1093/jnci/djq154. Epub 2010 Jun 18.
5
Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging.
Radiology. 2010 Jul;256(1):176-83. doi: 10.1148/radiol.10091147. Epub 2010 May 26.
6
Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?
BJU Int. 2010 Nov;106(9):1303-8. doi: 10.1111/j.1464-410X.2010.09346.x.
7
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.
Radiology. 2010 Apr;255(1):89-99. doi: 10.1148/radiol.09090475.
8
Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy.
BJU Int. 2010 Oct;106(7):991-7. doi: 10.1111/j.1464-410X.2010.09291.x. Epub 2010 Mar 9.
9
Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy.
Clin Cancer Res. 2010 Mar 15;16(6):1875-83. doi: 10.1158/1078-0432.CCR-09-2195. Epub 2010 Mar 2.
10
Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
J Magn Reson Imaging. 2010 Mar;31(3):625-31. doi: 10.1002/jmri.22075.
Zotero 插件